NCT06736886

Brief Summary

Breastfeeding is an important condition for the health of the mother and the baby, which is the most difficult for mothers after birth. Since it is an important practice for both the mother and the baby, the evaluation and reduction of the mother's stress factors can help the hospital to regulate the lighting of the breastfeeding room. In addition, setting the light color temperature to a more appropriate kelvin can make a positive contribution to the hospital in terms of costs. For this purpose, when researchers look at the literature, we have not come across a randomized controlled study examining the effect of the light color temperature applied during breastfeeding on the mother's stress, anxiety, peace and breastfeeding motivation. Researchers' purpose is to determine the effect of the light color temperature applied during breastfeeding on the mother's stress, anxiety, peace and breastfeeding motivation.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2024

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 5, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

December 17, 2024

Completed
8 days until next milestone

Study Start

First participant enrolled

December 25, 2024

Completed
5 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2025

Completed
Last Updated

December 17, 2024

Status Verified

December 1, 2024

Enrollment Period

5 days

First QC Date

December 5, 2024

Last Update Submit

December 15, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • stress scale

    QUESTIONNAIRE

    2 minutes

  • anxiety scale

    QUESTIONNAIRE

    2 minutes

Study Arms (2)

Intervention group

EXPERIMENTAL

Light application

Other: Light application

control group

PLACEBO COMPARATOR

Light application

Other: Light application

Interventions

Light application

Intervention groupcontrol group

Eligibility Criteria

Age18 Hours - 45 Hours
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Mothers who have given birth for the first time,
  • being 18 years of age and older,
  • volunteering.

You may not qualify if:

  • Being a mother who has given birth to more than one child,
  • having any problem that prevents communication (such as not knowing Turkish, having hearing, speaking and understanding disorders),
  • receiving psychiatric treatment (pharmacotherapy or psychotherapy),
  • having a disease that prevents vision.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Central Study Contacts

Emine Yıldırım, Assistant Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

December 5, 2024

First Posted

December 17, 2024

Study Start

December 25, 2024

Primary Completion

December 30, 2024

Study Completion

January 15, 2025

Last Updated

December 17, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Can be shared when necessary